RecruitingNot ApplicableNCT04103567

Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers

Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Therapy in Rectal Cancers: Focus on Cyclomodulin-producing Escherichia Coli


Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Enrollment

220 participants

Start Date

Jan 14, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this project is to determine in a non-invasive manner (fecal samples) the predictive value of the intestinal microbiota and the presence of genotoxin-producing bacteria on the response to neoadjuvant treatment in rectal cancer. This could lead to a better understanding and selection of patients for personalized treatment in rectal cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether the bacteria living in your gut (your microbiome) might affect how well rectal cancer responds to treatment before surgery (called neoadjuvant therapy). Researchers will collect stool samples to study these bacteria. **You may be eligible if...** - You have been diagnosed with rectal cancer (specifically in the lower or middle rectum, stages II or III) - You are scheduled to receive treatment such as radiation and/or chemotherapy before surgery - You are 18 years old or older **You may NOT be eligible if...** - You have taken antibiotics in the month before the stool sample is collected - You already have a colostomy bag (ostomy) - You have previously been treated for rectal cancer - You are pregnant or breastfeeding - You have had other cancers in the past 5 years (with some exceptions) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiological collection

Fecal samples collected at different times : during inclusion consultation with surgeon, after neoadjuvant treatment and before surgery.


Locations(2)

Institut régional du Cancer de Montpellier

Montpellier, Hérault, France

CHU Clermont-Ferrand

Clermont-Ferrand, Puy De Dôme, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04103567


Related Trials